logo
logo

Os Therapies Completes $6 Million Series A Funding Round

Apr 20, 2021•over 4 years ago

Amount Raised

$6 Million

RockvilleHealth Care

Description

OS Therapies, a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat and cure Osteosarcoma (OS) and other deadly cancers in kids and adults including ovarian, esophageal, endometrial and lung cancers, today announced the closing of a $6 million Series A round of funding.

Company Information

Company

OS Therapies

Location

15825 SHADY GROVE ROAD

Rockville, Maryland, United States

About

OS Therapies is a clinical stage research company focusing on therapeutic treatments for Osteosarcoma, Breast Cancer and other solid tumors with two platform technologies: OST-HER2 to prevent metastasis and OST-tADC to debulk solid tumors.

Related People